Items of recent pandemic news: Boosters approved for kids 5-11; the cause of severe Covid-19; two new vaccines built on different technology bases; immune evasiveness of two Omicron sub-variants; Paxlovid developments; and much more. Plus a frippery. The pandemic sputters … Continue reading →
This newsletter is tapering down. For 25 months I have been documenting the medical and scientific history of this extraordinary time. The country now acts as if it is over; what urgency the pandemic still commanded is leaching out. Herewith … Continue reading →
Items of recent pandemic news: Moderna announces preliminary results for their vaccine in children; the White House rolls out the one-stop information site covid.gov; FDA authorizes a fourth shot for older adults; and much more. Plus a frippery. Apologies to … Continue reading →
Items of recent pandemic news: Merck will allow other countries to make molnupiravir; why it’s better to be vaccinated than just recovered; an antidepressant that improves Covid-19 outcomes; and the CDC’s vote on vaccines for kids. Plus a frippery. CDC … Continue reading →
Two items of recent pandemic news: Billions to develop antivirals that can be taken by mouth; and a hard fail in a vaccine Phase III trial. Plus news briefs and a frippery. CureVac falls flat You may have heard by … Continue reading →
Two items of recent pandemic news: Studies point to long-lasting, possibly lifelong immunity from natural infection; and rapid developments in the highly political question of where SARS-CoV-2 came from. Plus news briefs and a pair of fripperies. Origin, again It … Continue reading →
Herewith three items of pandemic news you may have missed recently: A caution for those scheduling mammograms around the time of vaccination; sterilizing immunity from vaccines; and peptides for prevention and treatment. Plus news briefs and a frippery. Peptides Dr. … Continue reading →
Herewith three items of pandemic news you may have missed recently: A promising antiviral; a rare blood disorder perhaps related to vaccination; and the prospects for children getting vaccinated. Plus news briefs and a frippery. When will kids get vaccinated? … Continue reading →
Herewith three items of pandemic news you may have missed recently: Llama antibodies redux; two new viral variants out of Ohio; and the function of that second shot of vaccine. Plus news briefs and a frippery. What the second shot … Continue reading →
Herewith three items of pandemic news you may have missed recently: Infected gorillas; inhalable therapies and prophylactics; and the greater difficulty of testing new vaccine candidates once some have been authorized. Plus the accustomed frippery. After authorized vaccines, testing later … Continue reading →
Some pandemic news you may have missed recently: How the upcoming time of vaccine purgatory will go down; two vaccines that hit a snag; and an antiviral compound that blocks SARS-CoV-2 transmission in ferrets. Plus a frippery. An antiviral that … Continue reading →
Herewith three items of pandemic news you may have missed recently: troubling details on Long Covid; news from the treatment front; and Minnesota’s Covid notification app. Plus the accustomed frippery. Minnesota’s Covid notification app Yesterday I downloaded and installed COVIDaware … Continue reading →
Herewith three items of pandemic news you may have missed recently: mental health associations with Covid-19; an anti-depressant possibly protective against worsening disease; and using testing to shorten the time of quarantine. Plus the usual frippery. OCD drug fluvoxamine may … Continue reading →
If you haven’t seen the movie Fight Club, you probably still know the first rule of Fight Club: don’t tell anyone about Fight Club. Well, Covid-19 (or in my case cancer) Fight Club turns this rule on its head: tell … Continue reading →
By now you’ve heard that remdesivir has been shown to reduce the duration of Covid-19 illness in some patients, and that the White House’s Dr. Deborah Birx has been tasked with helping to coordinate its distribution to where it is … Continue reading →
